Select the region that best fits your location or preferences.
This setting controls the language of the user interface, including buttons, menus, and all site text. Select your preferred language for the best browsing experience.
Select the languages for job listings you want to see. This setting determines which job advertisements will be displayed to you.
A World-Class Research Environment at the Nexus of Biology, Engineering, and Physical Sciences
The Biotechnology and Bioengineering group led by Prof. Dr. Martin Fussenegger at the Department of Biosystems Science and Engineering (D-BSSE) of ETH Zurich in Basel invites exceptional candidates to apply for a PhD position in pioneering projects at the intersection of synthetic biology, nanotechnology, and bioelectronics.
The D-BSSE is ETH Zurich's first truly interdisciplinary research department uniting theoretical and experimental biology with advanced bioengineering and fostering close collaborations with leaders in materials science, physics, and chemistry to drive transformative advances in systems biology, biotechnology, and synthetic biology. Situated in Basel, Switzerland, at the heart of the BioValley, a tri-national region that hosts 40% of the global life sciences industry and numerous major pharmaceutical companies, the D-BSSE offers a unique environment for high-impact translational research with unparalleled access to academic and industrial expertise.
Advancing the Frontiers of Bioelectronics and Synthetic Biology
Our group integrates state-of-the-art synthetic biology with advanced nanotechnology, and electrogenetic interfaces to engineer human cells for next generation bioelectronic medicine, designing programmable cells that respond to electrical, electromagnetic, acoustic and biochemical cues to achieve wireless, real-time control of therapeutic protein expression and metabolic regulation. Leveraging innovative platforms such as direct-current-actuated regulation, electromagnetic programming of wireless expression, and closed-loop systems, we aim to translate these technologies into clinically relevant, minimally invasive therapies for cancer, as well as metabolic, neurodegenerative, autoimmune, and infectious diseases.
Applications must be submitted exclusively through our online application portal and should include:
Applications sent via e-mail or post will not be considered. For further information visit our group website, consult our published work, or contact Professor Martin Fussenegger ([email protected]).
ETH Zürich is well known for its excellent education, ground-breaking fundamental research and for implementing its results directly into practice.
Visit the employer page